Pasithea Therapeutics Corp.
KTTA | NASDAQ
$0.51
-$0.01 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.49
-$0.02 (-3.73%)
Pre-market:
Sep 22, 2026, 4:27 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.44 | -0.25 | -0.57 | -1.24 | -18.73 | -1.2K |
PEG Ratio | 0.01 | 0.10 | -0.02 | 0 | -0.01 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | 2.7K | n/a |
PB Ratio | 0.16 | 0.23 | 0.39 | 0.38 | 0.79 | 203.23 |
P/FCF Ratio | 0 | -0.25 | -0.67 | -1.17 | -12.74 | -1.27K |
P/OCF Ratio | 0 | -0.25 | -0.68 | -1.18 | -12.83 | -1.27K |
OCF/S Ratio | n/a | n/a | n/a | n/a | -21.07K | n/a |
Debt / Equity Ratio | n/a | n/a | 0 | 0.01 | n/a | n/a |
Quick Ratio | 11.35 | 6.58 | 6.34 | 18.15 | 119.17 | 37.55 |
Current Ratio | 11.35 | 6.58 | 6.34 | 18.15 | 119.17 | 37.55 |
Asset Turnover | n/a | n/a | n/a | n/a | 0 | n/a |
Interest Coverage | n/a | n/a | n/a | -123.42K | -8.87K | n/a |
Return on Equity | -36.99% | -94.06% | -68.22% | -32.79% | -4.23% | -25.47% |
Return on Assets | -33.91% | -86.55% | -61.12% | -30.85% | -4.08% | -24.79% |
Return on Invested Capital | -37.74% | -95.35% | -67.81% | -28.96% | -8.52% | -25.47% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | -14.69% | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | -14.43K% | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | -14.43K% | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | -29.93K% | n/a |
FCF Margin | n/a | n/a | n/a | n/a | -21.22K% | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | -29.92K% | n/a |
Add to Watchlist
Select watchlists to add or remove KTTA